Healy James

Director, 10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Feb 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$86K
Net Open-Market Flow
-$86K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2023Disposed to issuer(D)20K0
Feb 24, 2023Tender(U)10K20K
Feb 24, 2023Tender(U)6.1M0
Nov 28, 2022Sell(S)6K$14.32$86K0

Transaction Codes

D
Disposition to the issuer
U
See SEC Form 4 code table
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-013481) within minutes of acceptance. Every field above traces to the original document. Verify it directly: